Scinai Immunotherapeutics (SCNI) Equity Average (2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Scinai Immunotherapeutics (SCNI) has disclosed Equity Average for 1 consecutive years, with $9.0 million as the latest value for Q4 2025.

• Quarterly Equity Average changed N/A to $9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $9.0 million for FY2025, N/A changed from the prior year.
• Equity Average hit $9.0 million in Q4 2025 for Scinai Immunotherapeutics.
• In the past five years, Equity Average ranged from a high of $9.0 million in Q4 2025 to a low of $9.0 million in Q4 2025.

Peer Comparison